Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

The Lancet Oncology

Fecha de publicación: 11 September 2019

DOI: https://doi.org/10.1016/S1470-2045(19)30456-5

Autores: Melina Arnold, PhD., Mark J Rutherford, PhD., Aude Bardot, MSc., Jacques Ferlay, ME., Therese M-L Andersson, PhD
Tor Åge Myklebust, PhD., et al.

Background: Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends.